Form 483

Neogen Corporation Form 483, 2012-01-09

FDA issued a Form 483 to Neogen Corporation on 2012-01-09 with 6 public-safe observations.

483· Form 483 issued6 observations

Neogen Corporation · Lansing, United States · Issued January 9, 2012

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Jan 2012
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Brian P Putz

9 Jan 2012
21 CFR 820.25(b)

Training records

Cited by Brian P Putz

9 Jan 2012
21 CFR 820.30(i)

Design changes - Lack of or Inadequate Procedures

Cited by Brian P Putz

9 Jan 2012
21 CFR 820.40

Procedures not adequately established or maintained

Cited by Brian P Putz

9 Jan 2012
21 CFR 820.50

Purchasing controls, Lack of or inadequate procedures

Cited by Brian P Putz

Inspected site

NCNeogen CorporationLansing, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.25(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.40Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere